Adalimumab in the Management of Isotretinoin-Induced Acne Fulminans: Report of a Case.
Acne fulminans
Adalimumab
Isotretinoin
Treatment
Journal
Skin appendage disorders
ISSN: 2296-9195
Titre abrégé: Skin Appendage Disord
Pays: Switzerland
ID NLM: 101670617
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
15
05
2020
accepted:
05
10
2020
entrez:
2
4
2021
pubmed:
3
4
2021
medline:
3
4
2021
Statut:
ppublish
Résumé
Acne fulminans (AF) is a rare, acute, and severe form of acne vulgaris often associated with systemic symptoms. Its treatment is challenging and controversial. We report a case of isotretinoin-induced AF (IIAF) in a 12-year-old boy resistant to traditional therapies (oral steroids and isotretinoin). The patient was successfully treated with adalimumab that can be considered an effective off-label option in the treatment of resistant IIAF in children.
Identifiants
pubmed: 33796557
doi: 10.1159/000512032
pii: sad-0007-0115
pmc: PMC7991494
doi:
Types de publication
Case Reports
Langues
eng
Pagination
115-119Informations de copyright
Copyright © 2021 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Int Wound J. 2019 Aug;16(4):1047-1048
pubmed: 30938050
An Bras Dermatol. 2017;92(5 Suppl 1):8-10
pubmed: 29267432
J Dtsch Dermatol Ges. 2019 Aug;17(8):837-838
pubmed: 31056852
J Am Acad Dermatol. 1993 Apr;28(4):572-9
pubmed: 7681856
Exp Dermatol. 2016 Feb;25(2):153-5
pubmed: 26477999
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e43-e45
pubmed: 29956847
J Eur Acad Dermatol Venereol. 2011 May;25(5):501-7
pubmed: 21029206
J Am Acad Dermatol. 2017 Jul;77(1):109-117
pubmed: 28619551
J Pediatr. 2018 Oct;201:166-175.e3
pubmed: 30054164
Indian J Dermatol Venereol Leprol. 2018 Jan-Feb;84(1):104-107
pubmed: 29284764
Dermatology. 2017;233(2-3):136-140
pubmed: 28768255
Br J Dermatol. 1999 Aug;141(2):307-9
pubmed: 10468806